Improving the outlook for children with Philadelphia positive ALL
Unravelling clinical heterogeneity in Philadelphia positive ALL
We have been funding expert research since 2016, aiming to ensure that every child and young person has a safe and effective treatment for their cancer, and that they can live long and happy lives post-treatment.
Unravelling clinical heterogeneity in Philadelphia positive ALL
Improving prediction of relapse, treatment delivery and outcomes for children with renal tumours in the UK
High-risk rhabdomyosarcoma patient derived 3D cultures to screen for novel drugs that enhance sensitivity to standard treatment
Minimal residual disease detection of ependymoma by microRNA biomarker profile evaluation as part of SIOP Ependymoma II trial
Improving the diagnosis of children’s brain tumours by Functional Radiomics
Developing leukaemic biomarkers to enable personalised CNS-directed therapy